Compare Etsy Inc (ETSY) vs Eli Lilly And Co (LLY) Price & Performance

ETSY trades at $75.14, up 5.11% today, reflecting strong momentum. The stock shows a bullish technical outlook with consistent earnings beats and a 53.33% analyst buy rating. Recent news highlights AI integration to enhance personalization and renewed payment partnerships, supporting growth. Revenue reached $2.88B in 2025, though net income margin dipped to 5.65%. Cash flow improved with $593.18M net inflow in 2025, but high debt and negative equity pose financial risks.

The outlook is cautiously optimistic with a consensus price target of $85.94 offering ~14% upside. Strengths include robust gross margins and strategic AI initiatives, but risks involve elevated valuation multiples, competitive pressures, and sensitivity to consumer spending trends. Investors should weigh growth potential against balance sheet concerns.

Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.

LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.